Updated survival outcomes of NEJ005/TCOG0902: a randomised phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations
Oizumi, Satoshi, Sugawara, Shunichi, Minato, Koichi, Harada, Toshiyuki, Inoue, Akira, Fujita, Yuka, Maemondo, Makoto, Watanabe, Satoshi, Ito, Kazuhiko, Gemma, Akihiko, Demura, Yoshiki, Fukumoto, ShiniVolume:
3
Language:
english
Journal:
ESMO Open
DOI:
10.1136/esmoopen-2017-000313
Date:
February, 2018
File:
PDF, 815 KB
english, 2018